Published in N Engl J Med on March 05, 1992
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut (2001) 4.22
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Surveillance guidelines after removal of colorectal adenomatous polyps. Gut (2002) 2.71
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc (2009) 2.55
Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer (2011) 2.01
Comparative study of conventional colonoscopy and pan-colonic narrow-band imaging system in the detection of neoplastic colonic polyps: a randomized, controlled trial. J Gastroenterol (2008) 2.00
Colorectal cancer. BMJ (1992) 1.97
Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96
A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci U S A (2003) 1.84
Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut (1999) 1.84
Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology (2006) 1.78
Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract (1996) 1.78
Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy. Gut (2004) 1.67
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63
Screening for colorectal cancer. Scoop, 'scope, or skip? Can Fam Physician (1993) 1.62
Retracted Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clin Cancer Res (2008) 1.51
The diagnostic and therapeutic roles of colonoscopy: a review. Surg Endosc (2001) 1.46
Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut (1993) 1.39
Screening for colorectal cancer. BMJ (1994) 1.28
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol (2010) 1.26
The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol (2006) 1.23
Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol (2012) 1.21
Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study. Am J Hum Genet (2008) 1.10
American founder mutation for attenuated familial adenomatous polyposis. Clin Gastroenterol Hepatol (2007) 1.10
Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut (2015) 1.10
Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut (2000) 1.08
Sporadic duodenal adenoma is associated with colorectal neoplasia. Gut (2004) 1.07
Risk related surveillance following colorectal polypectomy. Gut (2002) 1.06
Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer (2001) 1.05
Korean guidelines for postpolypectomy colonoscopy surveillance. Clin Endosc (2012) 1.05
Surveillance of duodenal polyps in familial adenomatous polyposis: progress report. J R Soc Med (1994) 1.04
Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol (2011) 1.04
Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ (1995) 1.03
Gastrointestinal endoscopy nurse experience and polyp detection during screening colonoscopy. Clin Gastroenterol Hepatol (2008) 1.03
Can endoscopic ultrasound predict early rectal cancers that can be resected endoscopically? A meta-analysis and systematic review. Dig Dis Sci (2009) 1.02
Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol (2012) 1.02
Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut (1995) 1.01
Implementing screening for colorectal cancer. BMJ (1999) 1.01
Polyp size measurement at CT colonography: what do we know and what do we need to know? Radiology (2010) 1.00
Magnifying endoscopy with indigo carmine contrast for differential diagnosis of neoplastic and nonneoplastic colonic polyps. Dig Dis Sci (2004) 1.00
Colonoscopic yield of colorectal neoplasia in daily clinical practice. World J Gastroenterol (2009) 1.00
Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci (2012) 0.99
Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas. World J Gastroenterol (2010) 0.98
Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut (2005) 0.98
Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev (2005) 0.97
Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination. CMAJ (1994) 0.96
Local Excision vs. Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Gastrointest Cancer Res (2009) 0.95
Obesity is associated with an increased prevalence of advanced adenomatous colon polyps in a male veteran population. Dig Dis Sci (2009) 0.95
Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening--review of literature. Int J Colorectal Dis (2008) 0.94
FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis (2011) 0.92
Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med (2009) 0.92
Polyp measurement based on CT colonography and colonoscopy: variability and systematic differences. Eur Radiol (2009) 0.91
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis (2010) 0.90
Variation of agreement in polyp size measurement between computed tomographic colonography and pathology assessment: clinical implications. Clin Gastroenterol Hepatol (2008) 0.90
Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal Cancer. Am J Gastroenterol (2015) 0.89
Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr (2015) 0.87
Prevalence of advanced colonic polyps in asymptomatic Chinese. World J Gastroenterol (2005) 0.86
A prospective randomized study on computed virtual chromoendoscopy versus conventional colonoscopy for the detection of small colorectal adenomas. Dig Dis Sci (2009) 0.86
Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas. Dig Dis Sci (2003) 0.85
Screening sigmoidoscopy for colorectal cancer. N Engl J Med (1992) 0.85
Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention. World J Clin Oncol (2015) 0.84
Reduction of miss rates of colonic adenomas by zoom chromoendoscopy. Int J Colorectal Dis (2005) 0.84
Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia. Cancer Prev Res (Phila) (2013) 0.84
Colorectal cancer screening in asymptomatic populations. Gut (1995) 0.83
Current concepts in colorectal cancer prevention. Expert Rev Gastroenterol Hepatol (2009) 0.82
History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy. Int J Colorectal Dis (2005) 0.82
Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer (2010) 0.82
Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol (2009) 0.81
An endoscopic training model to improve accuracy of colonic polyp size measurement. Int J Colorectal Dis (2010) 0.81
Incidence of advanced adenomas of the rectosigmoid colon three years and five years after negative flexible sigmoidoscopy in 4010 patients. Dig Dis Sci (2003) 0.81
[Standardized and structured histopathological evaluation of colorectal polyps: a practical checklist against the background of the new WHO classification]. Pathologe (2011) 0.81
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81
Endoscopic measurement of polyp size using a novel calibrated hood. Gastroenterol Res Pract (2014) 0.81
Strategies for colon cancer prevention. EPMA J (2010) 0.80
The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline. Gut Liver (2015) 0.79
Comparison of p53 and bcl-2 expression in initial, synchronous, and metachronous colorectal adenomas. Surg Today (1999) 0.79
Fecal Tests: From Blood to Molecular Markers. Curr Colorectal Cancer Rep (2011) 0.79
A survey of colonoscopic surveillance after polypectomy. Ann Coloproctol (2014) 0.79
Predictive factors of proximal advanced neoplasia in the large bowel. Arch Med Sci (2014) 0.79
The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR). Br J Cancer (1993) 0.78
Non-compliance in surveillance for patients with previous resection of large (> or = 1 cm) colorectal adenomas. World J Gastroenterol (2006) 0.78
Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations. Fam Cancer (2014) 0.78
The history of colorectal cancer screening: a personal perspective. Dig Dis Sci (2015) 0.78
Characterization of the pathologic and endoscopic measurements of colorectal polyp sizes with a focus on sessile serrated adenoma and high-grade dysplasia. Int J Clin Exp Pathol (2014) 0.78
Retrieval of colorectal polyps following snare polypectomy: Experience of the multiple-suction technique in 602 cases. Int J Colorectal Dis (2008) 0.78
Colon cancer screening update and management of the malignant polyp. Clin Colon Rectal Surg (2005) 0.78
Protagonist: population based endoscopic screening for colorectal cancer. Gut (2003) 0.78
Quantification of proliferative activity in colorectal adenomas by mitotic counts: relationship to degree of dysplasia and histological type. J Clin Pathol (1995) 0.78
Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77
Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population. Dig Dis Sci (2010) 0.77
Incidence of rectosigmoid adenomatous polyps in subjects without prior colorectal adenoma or cancer: a prospective cohort study. Gut (1999) 0.77
Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut (1996) 0.77
Progress in preventing death from colorectal cancer. Br J Cancer (1995) 0.77
A Wilcoxon-type test for trend. Stat Med (1985) 13.22
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
The evolution of cancer of the colon and rectum. Cancer (1975) 9.05
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet (1993) 7.46
Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut (1967) 7.39
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Ischaemic colitis. Gut (1966) 5.51
Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer (1996) 5.24
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet (2002) 5.04
Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med (1966) 4.88
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet (1986) 4.55
The rectal biopsy appearances in Salmonella colitis. Histopathology (1978) 4.53
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol (1980) 4.13
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology (1986) 3.70
Solitary ulcer of the rectum. Gut (1969) 3.40
Clinical and pathological differentiation of Crohn's disease and proctocolitis. Gastroenterology (1968) 3.20
Mild cervical dyskaryosis: safety of cytological surveillance. Lancet (1992) 3.09
Crohn's disease of the anal region. Gut (1965) 3.05
Pseudo-carcinomatous invasion in adenomatous polyps of the colon and rectum. J Clin Pathol (1973) 3.01
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol (1982) 2.89
The clinical significance of invasion of veins by rectal cancer. Br J Surg (1980) 2.69
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet (1983) 2.67
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology (1977) 2.61
Aetiology of adenoma--carcinoma sequence in large bowel. Lancet (1978) 2.52
Reporting colorectal cancer. J Clin Pathol (1987) 2.50
Juvenile polyposis--a precancerous condition. Histopathology (1988) 2.47
Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol (2012) 2.45
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet (1975) 2.40
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Inflammatory bowel disease: the surgical pathology of Crohn's disease and ulcerative colitis. Hum Pathol (1975) 2.37
Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg (1984) 2.36
Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35
Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol (1987) 2.33
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Metachronous carcinoma of the large intestine and intestinal polyps. Proc R Soc Med (1967) 2.26
Numerical taxonomy and discriminant analysis applied to non-specific colitis. Q J Med (1973) 2.26
Squamous carcinoma of the colorectum and its genesis. J Pathol (1979) 2.07
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Colonic adenomas--a colonoscopy survey. Gut (1979) 2.01
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99
Evolution of cancer of the colon and rectum. Cancer (1974) 1.99
Cancer in ulcerative colitis. Gut (1966) 1.97
Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95
Crohn's disease of the colon and its distinction from diverticulitis. Gut (1968) 1.95
Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol (1988) 1.90
The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual Life Res (1996) 1.85
Inflammatory fibroid polyp of the gastrointestinal tract. Histopathology (1978) 1.84
Pathology and prognosis of carcinoma of the stomach. Br J Surg (1970) 1.83
Goblet cell carcinoid of the appendix. Cancer (1974) 1.81
A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen (2004) 1.81
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77
The use of cervicography in a primary screening service. Br J Obstet Gynaecol (1991) 1.76
Rectal biopsy in inflammatory bowel disease. N Engl J Med (1972) 1.76
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
Policy of local excision for early cancer of the colorectum. Gut (1977) 1.73
Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology (1981) 1.72
Medical audit of rectal biopsy diagnosis of inflammatory bowel disease. J Clin Pathol (1982) 1.72
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Right-sided diverticulosis of the colon. Br J Surg (1971) 1.70
Colonoscopic diagnosis of minimal change colitis in patients with a normal sigmoidoscopy and normal air-contrast barium enema. Lancet (1982) 1.68
Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut (1998) 1.68
Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut (1984) 1.66
Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet (1988) 1.66
Pelvic Recurrence after Excision of Rectum for Carcinoma. Br Med J (1963) 1.64
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med (2000) 1.59
Pathology of inflammatory bowel disease. Gastroenterol Jpn (1980) 1.58
Radiation-induced myelomatosis. N Engl J Med (1981) 1.58
Juvenile polyposis coli. J Med Genet (1966) 1.56
The clinical staging of rectal cancer. Br J Surg (1982) 1.55
The granuloma in Crohn's disease. Gut (1979) 1.54
Tamoxifen and contralateral breast cancer. Lancet (1985) 1.53
Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut (1991) 1.50
Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol (2001) 1.49
Predisposing causes of intestinal cancer. Curr Probl Surg (1970) 1.49
A clinicopathological study of acute colitis: the dilemma of transient colitis syndrome. Scand J Gastroenterol (1982) 1.47
Genetics of gastrointestinal polyposis. Gastroenterology (1978) 1.47
Collagenous colitis. Gut (1986) 1.47
A prospective study of plasma prolactin levels and subsequent risk of breast cancer. Int J Cancer (1981) 1.46
Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol (1993) 1.45
Proceedings: The diagnosis of pseudomembranous colitis by rectal biopsy. Gut (1974) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen (2001) 1.43
Ileal adenomas after colectomy in nine patients with adenomatous polyposis coli/Gardner's syndrome. Gastroenterology (1979) 1.41
Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. Eur J Cancer (2004) 1.40
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer (2008) 1.37
The adenoma-carcinoma sequence. Major Probl Pathol (1978) 1.35